Key result
Eight-variable perioperative model predicts post-neurosurgery VTE risk with an AUC of 0.85.
Why the study?
Venous thromboembolism occurs in 3.0% to 26% of neurosurgical patients, motivating the development of a clinical prediction model using machine learning and statistical methods.
Cohort (n=8,658)
Yes
A novel 8-variable clinical prediction model incorporating clinical factors and biomarkers accurately predicts the risk of venous thromboembolism following neurosurgery, potentially aiding in standardized primary VTE prevention.
Answers are grounded in this paper and cite their sources.
May support targeted VTE prophylaxis after neurosurgery; leaves open whether implementation improves outcomes in prospective trials.
BACKGROUND: Based on the literature and data on its clinical trials, the incidence of venous thromboembolism (VTE) in patients undergoing neurosurgery has been 3.0%~26%. We used advanced machine learning techniques and statistical methods to provide a clinical prediction model for VTE after neurosurgery. METHODS: All patients (n = 5867) who underwent neurosurgery from the development and retrospective internal validation cohorts were obtained from May 2017 to April 2022 at the Department of Neurosurgery at the Sanbo Brain Hospital. The clinical and biomarker variables were divided into pre-, intra-, and postoperative. A univariate logistic regression (LR) was applied to explore the 67 candidate predictors with VTE. We used a multivariable logistic regression (MLR) to select all significant MLR variables of MLR to build the clinical risk prediction model. We used a random forest to calculate the importance of significant variables of MLR. In addition, we conducted prospective internal (n = 490) and external validation (n = 2301) for the model. RESULTS: Eight variables were selected for inclusion in the final clinical prediction model: D-dimer before surgery, activated partial thromboplastin time before neurosurgery, age, craniopharyngioma, duration of operation, disturbance of consciousness on the second day after surgery and high dose of mannitol, and highest D-dimer within 72 h after surgery. The area under the curve (AUC) values for the development, retrospective internal validation, and prospective internal validation cohorts were 0.78, 0.77, and 0.79, respectively. The external validation set had the highest AUC value of 0.85. CONCLUSIONS: This validated clinical prediction model, including eight clinical factors and biomarkers, predicted the risk of VTE following neurosurgery. Looking forward to further research exploring the standardization of clinical decision-making for primary VTE prevention based on this model.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2023) conducted a cohort in Venous thromboembolism following neurosurgery (n=8,658). Clinical prediction model for VTE (8 perioperative variables) was evaluated on Prediction of objectively confirmed venous thromboembolism (VTE) after neurosurgery (AUC 0.85, 95% CI 0.815-0.885). A clinical prediction model incorporating eight perioperative variables successfully predicted the risk of venous thromboembolism following neurosurgery, achieving an AUC of 0.85 in the external validation cohort.
Synapse has enriched 10 related papers. Consider them for comparative context: